Safety and Efficacy of MT-4666

Clinical trial NCT01764243 · COMPLETED

Trial details

NCT number: NCT01764243
Sponsor: Tanabe Pharma Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2012-11-01
Primary completion: 2015-06-01
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.